logo
Home
Publications
About the Authors
About the Authors
Deutsch
Englisch
Contact
Impressum
Data Protection
Login
logo
Home
Publications
About the Authors
About the Authors
Deutsch
Englisch
Contact
Impressum
Data Protection
Login
Dr. Möhrke, Werner
Medical Department, Procter and Gamble Pharmaceuticals
Publications:
Switching from branded alendronate or risedronate to generic alendronate: effect on persistence with bisphosphonate therapy in Germany
Switching from branded alendronate or risedronate to generic alendronate: effect on persistence with bisphosphonate therapy in Germany
Beeinflusst die Umstellung von Risedronat oder Alendronat Originalprodukten auf Generika die Compliance (Persistenz)?
Effect of switching branded risedronate to branded or generic alendronate on medication compliance with weekly bisphosphonates: a cohort study utilizing the dapi prescription claims database